Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Mitchell Efros"'
Autor:
Aaron Katz, Mitchell Efros, Jed Kaminetsky, Kelli Herrlinger, Diana Chirouzes, Michael Ceddia
Publikováno v:
Therapeutic Advances in Urology, Vol 6 (2014)
Objectives: The objective of this study was to examine the effects of a green and black tea extract blend [AssuriTEA Men’s Health (AMH)] in men with lower urinary tract symptoms (LUTS). Methods: In this randomized, double-blind, placebo-controlled
Externí odkaz:
https://doaj.org/article/8ebaa7b485a84cb2a8bb4899a0fc7b77
Autor:
Yair Lotan, Jay D. Raman, Badrinath Konety, Siamak Daneshmand, Florian Schroeck, Shahrokh F. Shariat, Peter Black, Michel de Lange, Scott Asroff, Evan Goldfischer, Mitchell Efros, Kian Tai Chong, Eugene Huang, Hong Liang Chua, Qing Hui Wu, Siying Yeow, Weida Lau, Jin Yong, Molly Eng
Publikováno v:
Journal of Urology. 209:762-772
Autor:
Steven A. Kaplan, Jared Moss, Sheldon Freedman, Karl Coutinho, Ning Wu, Mitchell Efros, Dean Elterman, Richard D'Anna, Osvaldo Padron, Kaiser J. Robertson, Samuel Lawindy, Sandeep Mistry, Neal Shore, Jeffrey Spier, Jed Kaminestky, Brian Mazzarella, David Cahn, Mark Jalkut, Alexis Te
Publikováno v:
Journal of Urology. 209
Autor:
Yair, Lotan, Jay D, Raman, Badrinath, Konety, Siamak, Daneshmand, Florian, Schroeck, Shahrokh F, Shariat, Peter, Black, Michel, de Lange, Scott, Asroff, Evan, Goldfischer, Mitchell, Efros, Kian Tai, Chong, Eugene, Huang, Hong Liang, Chua, Qing Hui, Wu, Siying, Yeow, Weida, Lau, Jin, Yong, Molly, Eng
Publikováno v:
The Journal of urology.
Cxbladder tests are urinary biomarker tests for detection of urothelial carcinoma (UC). We developed enhanced Cxbladder tests that incorporate DNA analysis of 6 single-nucleotide polymorphisms (SNPs) for theTwo multicenter, prospective studies were u
Autor:
Andrew R. McCullough, Karl-Erik Andersson, Toby C. Chai, Victor W. Nitti, Arnold Melman, Sharon Jacobs, George J. Christ, Eric S. Rovner, Kelvin P. Davies, Mitchell Efros
Publikováno v:
Neurourology and Urodynamics
Aims Two phase 1 trials were performed in healthy women with the overactive bladder (OAB) syndrome and urodynamically demonstrated detrusor overactivity (DO), with the aim to demonstrate the safety and potential efficacy of URO‐902, which comprises
Autor:
Eric Rovner, Toby C. Chai, Sharon Jacobs, George Christ, Karl‐Erik Andersson, Mitchell Efros, Victor Nitti, Kelvin Davies, Andrew R. McCullough, Arnold Melman
Publikováno v:
Neurourology and Urodynamics. 39
Autor:
Stephen Richardson, Kenneth Goldberg, Ronald F. Tutrone, Jed Kaminetsky, Mitchell Efros, Sheldon Freedman, Barry Shepard, Jeffrey Snyder, Susan Kalota, James Bailen, Neal D. Shore, Richard Levin, Steven N. Gange, Alan Hay, Barton Wachs, Mohamed Bidair, Ivan Grunberger
Publikováno v:
World Journal of Urology. 36:801-809
These studies were undertaken to determine if fexapotide triflutate 2.5 mg transrectal injectable (FT) has significant long-term (LT) safety and efficacy for the treatment of benign prostatic hyperplasia (BPH). Two placebo controlled double-blind ran
Autor:
Anders Neijber, Laurence Belkoff, Gerald B. Brock, Glenn R. Cunningham, Mitchell Efros, Masakazu Ando, Marc Gittelman, Dario Carrara, Jules T. Mitchel
Publikováno v:
Endocrine Practice. 23:557-565
Objective: Testosterone replacement therapy is indicated for male hypogonadism. This study aimed to evaluate the efficacy and safety of testosterone gel 2% (Tgel) over 90 days. Methods: This phase 3, open-label, noncomparator study was conducted in a
Publikováno v:
Neurourology and urodynamics. 38(7)
Aims To compare the efficacy and safety of a neuromuscular external electrical stimulation device (INNOVO; "NMES") with an FDA-approved intravaginal device (iTouch sure; "comparator device") for the treatment of stress urinary incontinence (SUI). Met
Autor:
Emily Weng, Roger R. Dmochowski, Steven Abrams, Jed Kaminetsky, Mitchell Efros, Maria Cheng, David Sussman, Seymour Fein, Scott MacDiarmid
Publikováno v:
Journal of Urology. 197